NUMELVI is a tablet taken once daily, and it is the first of its kind, considered a second-generation Janus kinase inhibitor specifically designed to treat itch associated with allergic dermatitis, including atopic dermatitis, and to treat the clinical symptoms of atopic dermatitis in dogs. NUMELVI – the next generation of itch relief – is a new product for managing allergic dermatitis in dogs, offering selectivity, safety, and simplicity. Active Ingredients NUMELVI contains Atenvistinib. Indications For the treatment of itch associated with allergic dermatitis, including atopic dermatitis in dogs. For the treatment of inflammation and clinical symptoms of atopic dermatitis in dogs.
Expires on March 31, 2029